NL EN
Home About us     Our story: Chiesi Belgium     Chiesi Worldwide     Mission and values     History     B Corp Therapeutic areas      Respiratory      Neonatology      Rare diseases      Special care Sustainability     We Act     Climbing for Life     Annual reports Jobs Research & Development     Research & Development     Pipeline Media Contact
  • Home
  • |
  • Contact
  • |
  • SpeakUp&BeHeard
  • |
  • Chiesi Group
  • NL
  • EN
  • FR
Welcome to Chiesi
Belgium
Enter at least 3 characters
  • About us
    • Our story: Chiesi Belgium
    • Chiesi Worldwide
    • Mission and values
    • History
    • B Corp
  • Therapeutic areas
    • Respiratory
    • Neonatology
    • Rare diseases
    • Special care
  • Sustainability
    • We Act
    • Climbing for Life
    • Annual reports
  • Jobs
  • Research & Development
    • Research & Development
    • Pipeline
  • Media
  • Contact
  • Respiratory
    Within the area respiratory diseases Chiesi is specialized in, among others, the treatement of...
    Respiratory
    Within the area respiratory diseases Chiesi is specialized in, among others, the treatement of...
  • Neonatology
    Preterm babies are given maximum support thanks to extra care and medicines
    Neonatology
    Preterm babies are given maximum support thanks to extra care and medicines
  • Rare diseases
    People with rare diseases find new hope thanks to Chiesi ’s research & innovation.
    Rare diseases
    People with rare diseases find new hope thanks to Chiesi ’s research & innovation.
  • Special care
    Chiesi also focuses its attention on the treatment and care of patients suffering from...
    Special care
    Chiesi also focuses its attention on the treatment and care of patients suffering from...
  • NEWS
    Chiesi Group and Affibody collaborate to develop...
  • NEWS
    Chiesi appoints Giuseppe Accogli as new Group CEO
  • NEWS
    Chiesi accelerates path toward full...
  • NEWS
    World Asthma Day 2021: Press release
  • NEWS
    CHIESI CONTINUES CULTURAL TRANSFORMATION WITH NEW...
  • NEWS
    Chiesi Group: performance is up in 2020
  • NEWS
    European market authorisation for the extrafine...
  • NEWS
    COLLABORATION BETWEEN KAIA HEALTH AND CHIESI GROUP
  • NEWS
    COPD Day 2020
  • NEWS
    Collaboration between Moderna and Chiesi Group
© 2023 Chiesi SA/NV
Telecomlaan / Avenue Telecom 9 PO Box 4 1831 Diegem
Belgium
T +32 (0)2 788 42 00
info.be@chiesi.com
Approval n°: 1381/TCP/InfoBrochure/BE/03-2023 – MARCH 2023
Latest update: 2023-03-154
  • Terms of Use
  • Privacy and Cookie Policy
  • Code of Interdependence
  • Code of Conduct
  • Reporting adverse events
  • Transparency
  • SpeakUp&BeHeard
CHIESI ON THE WEB
follow us on:
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.